Trends and changes in clostridium difficile diagnostic policies and their impact on the proportion of positive samples: A national survey

Clinical Microbiology and Infection

Volumn 20, Issue 11, 2014, Pages O904-O910

  Adler, A ^a   Schwartzberg, Y ^a   Samra, Z ^b   Schwartz, O ^c   Carmeli, Y ^a   Schwaber, M J ^a   Keness, Yoram ^d   Sela, Shifra ^e   Freeman, Sarit ^f   Zucker, Miriam ^g   Shaked Mishan, Pninit ^h   Bernstein, Rita ⁱ   Moskovitch, Inna ^j   Geffen, Yuval ^k   Treigerman, Orit ^l   Feig, Bezalel ^m   Ken Dror, Shifra ⁿ   Leventhal, Shulamit ^o   Taran, Diana ^p   Parizada, Miriam ^p   Golan, Orit ^q   Benenson, Shmuel ^r   Yishai, Ruty ^s   more..

^a National Center for Infection Control   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c Wolfson Medical Centre   (Israel)

^d HAEMEK MEDICAL CENTER   (Israel)

^e WESTERN GALILEE HOSPITAL   (Israel)

^f HILLEL YAFFE MEDICAL CENTER   (Israel)

^g Sieff Hospital   (Israel)

^h Carmel MC   (Israel)

ⁱ Kaplan MC   (Israel)

^j HASHARON HOSPITAL   (Israel)

^k Rambam MC   (Israel)

^l Siach Sod Rehabilitation Center for Children With Special Needs   (Israel)

^m Clalit HS Jerusalem   (Israel)

ⁿ Clalit HS Nesher   (Israel)

^o Clalit HS Central Laboratory   (Israel)

^p Maccabi HS   (Israel)

^q Bnei Zion MC   (Israel)

^r HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^s MINISTRY OF HEALTH   (Israel)

more..

Author keywords

Clostridium difficile; Glutamate dehydrogenase antigen; Guidelines; National; Polymerase chain reaction; Pre analytical screening

Indexed keywords

GLUTAMATE DEHYDROGENASE; BACTERIAL ANTIGEN; BACTERIAL TOXIN;

ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; ENZYME IMMUNOASSAY; GENERAL HOSPITAL; HEALTH MAINTENANCE ORGANIZATION; HEALTH SURVEY; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; CLOSTRIDIUM INFECTIONS; DIARRHEA; EPIDEMIOLOGICAL MONITORING; GENETICS; HEALTH CARE POLICY; INFORMATION PROCESSING; ISOLATION AND PURIFICATION; ISRAEL; MICROBIOLOGICAL EXAMINATION; MOLECULAR DIAGNOSIS; PROCEDURES;

CLOSTRIDIUM DIFFICILE;

ANTIGENS, BACTERIAL; BACTERIAL TOXINS; BACTERIOLOGICAL TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DATA COLLECTION; DIARRHEA; EPIDEMIOLOGICAL MONITORING; HEALTH POLICY; HOSPITALS, GENERAL; HUMANS; ISRAEL; MOLECULAR DIAGNOSTIC TECHNIQUES; PRACTICE GUIDELINES AS TOPIC;

EID: 84917730437     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12634     Document Type: Article

References (17)

1. Gerding DN. Global epidemiology of Clostridium difficile infection in 2010. Infect Control Hosp Epidemiol 2010; 31(Suppl 1): S32-S34.
2. Carroll KC, Loeffelholz M. Conventional versus molecular methods for the detection of Clostridium difficile. J Clin Microbiol 2011; 49(9 Suppl): S49-S52.
3. McDonald LC, Killgore GE, Thompson A et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353: 2433-2441.
4. Burnham C-AD, Carroll KC. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 2013; 26: 604-630.
5. Cohen SH, Gerding DN, Johnson S et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-455.
6. Cheng AC, Ferguson JK, Richards MJ et al. Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile. Med J Aust 2011; 194: 353-358.
7. Crobach MJT, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 2009; 15: 1053-1066.
8. Ferguson JK, Cheng AC, Gilbert GL et al. Clostridium difficile laboratory testing in Australia and New Zealand: national survey results and Australasian Society for Infectious Diseases recommendations for best practice. Pathology 2011; 43: 482-487.
9. Könönen E, Rasinperä M, Virolainen A, Mentula S, Lyytikäinen O. Diagnostic trends in Clostridium difficile detection in Finnish microbiology laboratories. Anaerobe 2009; 15: 261-265.
10. Fitzpatrick F, Oza a, Gilleece A, O'Byrne A M, Drudy D. Laboratory diagnosis of Clostridium difficile-associated disease in the Republic of Ireland: a survey of Irish microbiology laboratories. J Hosp Infect 2008; 68: 315-321.
11. van Dorp S, Hensgens MPM, Virolainen A et al. Diagnostic testing and measurement of Clostridium difficile infections across Europe. Berlin: ECCMID, 2013; P1869.
12. Grotto I. Israeli Guidelines for the laboratory diagnosis of Clostridium difficile infections. Israel: Public Health Services, 2012.
13. Matas A. Israeli Guidelines for the laboratory diagnosis of Clostridium difficile infections. Israel: Public Health Services, 2000.
14. Swindells J, Brenwald N, Reading N, Oppenheim B. Evaluation of diagnostic tests for Clostridium difficile infection. J Clin Microbiol 2010; 48: 606-608.
15. Quinn CD, Sefers SE, Babiker W et al. C. Diff Quik Chek complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium difficile in stool specimens. J Clin Microbiol 2010; 48: 603-605.
16. Boyanton BL, Sural P, Loomis CR et al. Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection. J Clin Microbiol 2012; 50: 640-645.
17. Sharp SE, Ruden LO, Pohl JC et al. Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease. J Clin Microbiol 2010; 48: 2082-2086.